Follow
Emily Zabor
Emily Zabor
Associate Staff, Cleveland Clinic Department of Quantitative Health Sciences
Verified email at ccf.org - Homepage
Title
Cited by
Cited by
Year
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
T Shree, OC Olson, BT Elie, JC Kester, AL Garfall, K Simpson, ...
Genes & development 25 (23), 2465-2479, 2011
5782011
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
G Iyer, H Al-Ahmadie, N Schultz, AJ Hanrahan, I Ostrovnaya, AV Balar, ...
Journal of Clinical Oncology 31 (25), 3133, 2013
3262013
Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis
JM Scott, EC Zabor, E Schwitzer, GJ Koelwyn, SC Adams, TS Nilsen, ...
Journal of Clinical Oncology 36 (22), 2297, 2018
2762018
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma
AA Hakimi, H Furberg, EC Zabor, A Jacobsen, N Schultz, G Ciriello, ...
Journal of the National Cancer Institute 105 (24), 1862-1870, 2013
2742013
DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma
MY Teo, RM Bambury, EC Zabor, E Jordan, H Al-Ahmadie, ME Boyd, ...
Clinical cancer research 23 (14), 3610-3618, 2017
2392017
Guidelines for reporting of statistics for clinical research in urology
M Assel, D Sjoberg, A Elders, X Wang, D Huo, A Botchway, K Delfino, ...
BJU international 123 (3), 401-410, 2019
2332019
Genomic characterization of upper tract urothelial carcinoma
JP Sfakianos, EK Cha, G Iyer, SN Scott, EC Zabor, RH Shah, Q Ren, ...
European urology 68 (6), 970-977, 2015
2312015
Body mass index and metastatic renal cell carcinoma: clinical and biological correlations
L Albiges, AA Hakimi, W Xie, RR McKay, R Simantov, X Lin, JL Lee, ...
Journal of Clinical Oncology 34 (30), 3655, 2016
2192016
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer
HA Al-Ahmadie, G Iyer, BH Lee, SN Scott, R Mehra, A Bagrodia, ...
Nature genetics 48 (4), 356-358, 2016
1762016
A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma
K Kadota, K Suzuki, SS Kachala, EC Zabor, CS Sima, AL Moreira, ...
Modern pathology 25 (8), 1117-1127, 2012
1742012
Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results
DH Abramson, BP Marr, IJ Dunkel, S Brodie, EC Zabor, SJ Driscoll, ...
British journal of ophthalmology 96 (4), 499-502, 2012
1712012
Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
PH Kim, EK Cha, JP Sfakianos, G Iyer, EC Zabor, SN Scott, I Ostrovnaya, ...
European urology 67 (2), 198-201, 2015
1622015
Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors
A Bagrodia, BH Lee, W Lee, EK Cha, JP Sfakianos, G Iyer, EJ Pietzak, ...
Journal of Clinical Oncology 34 (33), 4000, 2016
1572016
Impact of smoking and smoking cessation on oncologic outcomes in primary non–muscle-invasive bladder cancer
M Rink, H Furberg, EC Zabor, E Xylinas, M Babjuk, A Pycha, Y Lotan, ...
European urology 63 (4), 724-732, 2013
1472013
Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection?
TA Moo, M Edelweiss, S Hajiyeva, M Stempel, M Raiss, EC Zabor, ...
Annals of surgical oncology 25, 1488-1494, 2018
1272018
Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
EJ Pietzak, EC Zabor, A Bagrodia, J Armenia, W Hu, A Zehir, S Funt, ...
European urology 75 (2), 231-239, 2019
1232019
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy
M Rink, EC Zabor, H Furberg, E Xylinas, B Ehdaie, G Novara, M Babjuk, ...
European urology 64 (3), 456-464, 2013
1232013
Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging
RA Lefkowitz, J Landa, S Hwang, EC Zabor, CS Moskowitz, NP Agaram, ...
Skeletal radiology 42, 809-818, 2013
1202013
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
J Casuscelli, N Weinhold, G Gundem, L Wang, EC Zabor, E Drill, PI Wang, ...
JCI insight 2 (12), 2017
1102017
FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma
K Kadota, C Colovos, K Suzuki, NP Rizk, MPS Dunphy, EC Zabor, ...
Annals of surgical oncology 19, 3598-3605, 2012
1062012
The system can't perform the operation now. Try again later.
Articles 1–20